1. The median overall survival for pembrolizumab versus chemotherapy was not statistically significant difference. 2. Common grade 3 or higher ...
1. Atezolizumab plus capecitabine + bevacizumab performed marginally better with regards to progression free survival in patients with metastatic colorectal ...
1. In this study, long-term high sulfur microbial diet was associated with increased risk of colorectal cancer. 2. Body weight ...
2 Minute Medicine is pleased to announce that we are launching Wellness Check, a new series dedicated to exploring new ...
1. A randomized controlled trial of patients with stage II and III rectal cancer found that adding oxaliplatin to the ...
1. Incomplete resection of colon segments was shown to significantly increase the risk of future neoplasia compared to segments with ...
1. Patients on adavosertib had both increased progression-free survival and better tumor control, as compared to patients being actively monitored ...
1. Progression-free survival was extended by the use capecitabine as compared to active monitoring, but at the expense of increased ...
1. In this retrospective cohort study investigating targeted therapy of programmed cell death receptor 1 and programmed cell death ligand ...
1. Although combining pembrolizumab to chemoradiotherapy as part of total neoadjuvant therapy after FOLFOX (5-fluorouracil, leucovorin, and oxaliplatin) treatment was ...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.